Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene)methylpyrrole derivatives as potential VEGFR-2/PDGFRβ inhibitors

Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene)methylpyrrole derivatives as potential VEGFR-2/PDGFRβ inhibitors

Abstract Background Tumor angiogenesis, essential for tumor growth and metastasis, is tightly regulated by VEGF/VEGFR and PDGF/PDGFR pathways, and therefore blocking those pathways is a promising therapeutic target. Compared to sunitinib, the C(5)-Br derivative of 2-pyrrolidone-fused (2-oxoindolin-3...

Full description

Bibliographic Details
Main Authors:	Ting-Hsuan Yang, Chun-I Lee, Wen-Hsin Huang, An-Rong Lee
Format:	Article
Language:	English
Published:	BMC 2017-08-01
Series:	Chemistry Central Journal
Subjects:	Multi-target kinase inhibitor VEGFR-2 inhibitor PDGFRβ inhibitor angiogenesis (2-oxoindolin-3-ylidene)methylpyrrole Hydrogen-bond-donating
Online Access:	http://link.springer.com/article/10.1186/s13065-017-0301-5

Similar Items

Synthesis and Evaluation of Novel 2-Pyrrolidone-Fused (2-Oxoindolin-3-ylidene)methylpyrrole Derivatives as Potential Multi-Target Tyrosine Kinase Receptor Inhibitors
by: Ting-Hsuan Yang, et al.
Published: (2017-05-01)

Synthesis of novel organophosphorus compounds via reaction of substituted 2-oxoindoline-3-ylidene with acetylenic diesters and triphenylphosphine or triphenyl phosphite
by: Mahsa Najafi, et al.
Published: (2024-03-01)

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
by: Mohammed S. Taghour, et al.
Published: (2022-12-01)

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
by: Estevez-Garcia Purificacion, et al.
Published: (2012-11-01)

Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2
by: Laura Parma, et al.
Published: (2020-06-01)

Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth
by: Brian C. Stagg, et al.
Published: (2014-11-01)

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies
by: Hazem Elkady, et al.
Published: (2022-12-01)

Determination of the inhibitory effects of N-methylpyrrole derivatives on glutathione reductase enzyme
by: Esma Kocaoğlu, et al.
Published: (2019-01-01)

Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer
by: Esraa A. Abdelsalam, et al.
Published: (2022-12-01)

Nitrate Ion Selective Electrode Based on Ion Imprinted Poly(N-methylpyrrole)
by: Ellen M. Bomar, et al.
Published: (2017-01-01)

Electrochemical preparation and in situ characterization of poly(3-methylpyrrole) and poly(3-methylpyrrole-cyclodextrin) films on gold electrodes
by: Arjomandi Jalal, et al.
Published: (2008-06-01)

Selection of Human Cytomegalovirus Mutants with Resistance against PDGFRα-Derived Entry Inhibitors
by: Kerstin Laib Sampaio, et al.
Published: (2021-06-01)

Poly(N-methylpyrrole) Film on ZnNi Plated Carbon Steel Electrode
by: Abdurrahman Akdag, et al.
Published: (2017-06-01)

Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
by: Moataz A. Shaldam, et al.
Published: (2023-12-01)

Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
by: Salwa Elmeligie, et al.
Published: (2019-01-01)

Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studies
by: Ibrahim H. Eissa, et al.
Published: (2024-01-01)

Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
by: Ibrahim H. Eissa, et al.
Published: (2022-12-01)

Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib
by: Linda Heintze, et al.
Published: (2020-11-01)

Synthesis of 5-(ethylsulfonyl)-2-methoxyaniline: An important pharmacological fragment of VEGFR2 and other inhibitors
by: Miroslav Murár, et al.
Published: (2013-01-01)

Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies
by: Eslam B. Elkaeed, et al.
Published: (2022-09-01)

Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies
by: Reda G. Yousef, et al.
Published: (2022-12-01)

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
by: Lei Wang, et al.
Published: (2024-01-01)

2-(2-Imino-1-methylimidazolidin-4-ylidene)hydrazinecarbothioamide
by: Abdul Amir H. Kadhum, et al.
Published: (2012-07-01)

Dibromido[N-(1-diethylamino-1-oxo-3-phenylpropan-2-yl)-N′-(pyridin-2-yl)imidazol-2-ylidene]palladium(II) dichloromethane monosolvate
by: Qilin Liu, et al.
Published: (2019-07-01)

1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies
by: Mohamed Hagras, et al.
Published: (2022-12-01)

Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors
by: Yu-Xiang Ma, et al.
Published: (2022-10-01)

Identification of Novel Cyanopyridones and Pyrido[2,3-<em>d</em>]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies
by: Tarfah Al-Warhi, et al.
Published: (2022-10-01)

Isatin-Hydrazones with Multiple Receptor Tyrosine Kinases (RTKs) Inhibitory Activity and In-Silico Binding Mechanism
by: Huda S. Al-Salem, et al.
Published: (2021-04-01)

Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β
by: Lingli Zhou, et al.
Published: (2018-07-01)

Functionalized Oxoindolin Hydrazine Carbothioamide Derivatives as Highly Potent Inhibitors of Nucleoside Triphosphate Diphosphohydrolases
by: Saira Afzal, et al.
Published: (2020-11-01)

M2 Macrophages Promote PDGFRβ+ Pericytes Migration After Spinal Cord Injury in Mice via PDGFB/PDGFRβ Pathway
by: Ziyu Li, et al.
Published: (2021-04-01)

Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects
by: Eslam B. Elkaeed, et al.
Published: (2022-07-01)

Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists
by: Mohamed A. Abdelgawad, et al.
Published: (2022-02-01)

Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2
by: Frangky Sangande, et al.
Published: (2020-10-01)

Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2
by: Ibrahim H. Eissa, et al.
Published: (2023-12-01)

Crystal structure of ethyl 2-cyano-2-(1,3-dithian-2-ylidene)acetate
by: Wafia Boukhedena, et al.
Published: (2018-01-01)

Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
by: Nashwa M. Saleh, et al.
Published: (2020-01-01)

Discovery of Small Molecules That Target Vascular Endothelial Growth Factor Receptor-2 Signalling Pathway Employing Molecular Modelling Studies
by: Shailima Rampogu, et al.
Published: (2019-03-01)

Design, Synthesis, and Biological Evaluation of Axitinib Derivatives
by: Na Wei, et al.
Published: (2018-03-01)

Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors
by: Boris Pinchuk, et al.
Published: (2016-04-01)